Factorial Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,000
Closed -$330K 86
2023
Q3
$330K Sell
19,000
-9,000
-32% -$188K 0.24% 74
2023
Q2
$583K Sell
28,000
-19,500
-41% -$424K 0.4% 70
2023
Q1
$1.12M Buy
47,500
+500
+1% +$13.4K 0.84% 51
2022
Q4
$1.31M Sell
47,000
-1,000
-2% -$25.6K 1% 34
2022
Q3
$1.12M Sell
48,000
-12,000
-20% -$362K 0.98% 41
2022
Q2
$2.02M Buy
60,000
+200
+0.3% +$7K 1.65% 20
2022
Q1
$2.09M Sell
59,800
-16,200
-21% -$554K 1.44% 24
2021
Q4
$2.31M Buy
76,000
+4,000
+6% +$130K 1.53% 22
2021
Q3
$2.36M Hold
72,000
1.61% 18
2021
Q2
$2.18M Buy
+72,000
New +$2.37M 1.47% 27

Other funds holding OGN

Factorial Partners's OGN Position: Q4 2023 in Review

Factorial Partners sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 19,000 shares — an estimated $330K sold.

Factorial Partners first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $2.36M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Factorial Partners reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Factorial Partners sold 19,000 Organon & Co shares in Q4 2023, an estimated $330K.
  • Factorial Partners first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Factorial Partners's Organon & Co position peaked at $2.36M in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Factorial Partners's 13F filing for Q4 2023, filed 13 Feb 2024.